Passage Bio (PASG) News Today → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free PASG Stock Alerts $1.27 -0.05 (-3.48%) (As of 11:43 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 3:32 AM | americanbankingnews.comPassage Bio (NASDAQ:PASG) PT Lowered to $13.00 at Canaccord Genuity GroupMay 16, 2024 | americanbankingnews.comEquities Analysts Issue Forecasts for Passage Bio, Inc.'s Q2 2024 Earnings (NASDAQ:PASG)May 16, 2024 | americanbankingnews.comPassage Bio, Inc. (NASDAQ:PASG) to Post Q1 2025 Earnings of ($0.20) Per Share, Wedbush ForecastsMay 15, 2024 | markets.businessinsider.comOptimistic Outlook for Passage Bio Amid Clinical and Financial Progress: Maintains Buy RatingMay 15, 2024 | msn.comPassage Bio Reports Promising Interim Data in FTD-GRN Treatment TrialMay 15, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Price Target Cut to $13.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group lowered their price objective on Passage Bio from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday.May 15, 2024 | marketbeat.comPassage Bio, Inc. (NASDAQ:PASG) Forecasted to Post Q1 2025 Earnings of ($0.20) Per SharePassage Bio, Inc. (NASDAQ:PASG - Free Report) - Investment analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for shares of Passage Bio in a research report issued on Tuesday, May 14th. Wedbush analyst L. Chico anticipates that the company will post earnings of ($0.20) peMay 14, 2024 | investorplace.comPASG Stock Earnings: Passage Bio Beats EPS for Q1 2024May 14, 2024 | globenewswire.comPassage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsMay 11, 2024 | americanbankingnews.comPassage Bio (NASDAQ:PASG) Trading Up 0.7%April 22, 2024 | finance.yahoo.comPassage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitApril 22, 2024 | globenewswire.comPassage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitMarch 29, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Trading Up 3.1%Passage Bio (NASDAQ:PASG) Trading Up 3.1%March 20, 2024 | finance.yahoo.comPASG Apr 2024 7.500 callMarch 16, 2024 | finance.yahoo.comPASG Apr 2024 5.000 callMarch 7, 2024 | marketbeat.comPassage Bio, Inc. (NASDAQ:PASG) Expected to Post Q1 2024 Earnings of ($0.33) Per SharePassage Bio, Inc. (NASDAQ:PASG - Free Report) - Equities researchers at Wedbush lifted their Q1 2024 earnings per share (EPS) estimates for shares of Passage Bio in a research note issued on Monday, March 4th. Wedbush analyst L. Chico now anticipates that the company will post earnings per shareMarch 6, 2024 | investorplace.comPASG Stock Earnings: Passage Bio Beats EPS for Q4 2023March 6, 2024 | marketbeat.comPassage Bio, Inc. to Post FY2028 Earnings of $0.05 Per Share, Wedbush Forecasts (NASDAQ:PASG)Passage Bio, Inc. (NASDAQ:PASG - Free Report) - Investment analysts at Wedbush issued their FY2028 earnings per share (EPS) estimates for shares of Passage Bio in a report issued on Monday, March 4th. Wedbush analyst L. Chico expects that the company will post earnings of $0.05 per share for theMarch 5, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Given "Buy" Rating at Canaccord Genuity GroupCanaccord Genuity Group reiterated a "buy" rating and issued a $14.00 target price on shares of Passage Bio in a research report on Tuesday.March 5, 2024 | finance.yahoo.comPassage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramMarch 4, 2024 | globenewswire.comPassage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsMarch 3, 2024 | msn.comPassage Bio to Showcase Advancements at Major Health Care ConferencesMarch 3, 2024 | marketbeat.comPassage Bio (PASG) Set to Announce Quarterly Earnings on MondayPassage Bio (NASDAQ:PASG) will be releasing earnings on Monday, March 4, Yahoo Finance reports.February 27, 2024 | globenewswire.comPassage Bio to Participate in Upcoming Investor ConferencesFebruary 20, 2024 | investing.comPassage Bio Inc (PASG)February 16, 2024 | investing.comPASG/USD - Passage US DollarFebruary 12, 2024 | finance.yahoo.comWe Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth CarefullyFebruary 2, 2024 | msn.comPassage Bio CEO to Address Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comPassage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceDecember 21, 2023 | benzinga.comPassage Bio Stock (NASDAQ:PASG) Dividends: History, Yield and DatesDecember 20, 2023 | msn.comNeurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic PrioritiesDecember 20, 2023 | markets.businessinsider.comPassage Bio Announces Initial Clinical Data From Phase 1/2 UpliFT-D Trial On PBFT02December 20, 2023 | finance.yahoo.comPassage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNovember 22, 2023 | morningstar.comPassage Bio Inc Ordinary SharesNovember 15, 2023 | benzinga.comPassage Bio Stock (NASDAQ:PASG) Earnings Dates and Earning CallsNovember 15, 2023 | markets.businessinsider.comPassage Bio Earns Buy Rating Based on Robust Financial Position and Promising AAV1-based GT PBFT02 TrialNovember 13, 2023 | fr.investing.comLe BPA de Passage Bio a manqué les attentes de 0,03$, le CA conforme aux prévisionsNovember 13, 2023 | msn.comPassage Bio GAAP EPS of -$0.49 misses by $0.03November 13, 2023 | benzinga.comRecap: Passage Bio Q3 EarningsNovember 13, 2023 | finance.yahoo.comPassage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNovember 10, 2023 | morningstar.comPassage Bio Inc Ordinary Shares PASGOctober 30, 2023 | benzinga.comPassage Bio to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology ConferenceOctober 30, 2023 | finance.yahoo.comPassage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceOctober 8, 2023 | news.yahoo.comVenezuelan migrants pay for passage to Trinidad with sex workSeptember 25, 2023 | benzinga.comPassage Bio to Present at Chardan's 7th Annual Genetic Medicines ConferenceSeptember 25, 2023 | finance.yahoo.comPassage Bio to Present at Chardan’s 7th Annual Genetic Medicines ConferenceSeptember 5, 2023 | finance.yahoo.comIs Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?August 11, 2023 | finance.yahoo.comLab Notes: Almac Group starts work on $65M Montco expansion expected to create 355 jobsAugust 9, 2023 | nasdaq.comChardan Capital Maintains Passage Bio (PASG) Buy RecommendationAugust 7, 2023 | fr.investing.comLe BPA de Passage Bio a dépassé les attentes de 0,03$, le CA conforme aux prévisions Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25! Click for Zack's full report PASG Media Mentions By Week PASG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PASG News Sentiment▼0.830.42▲Average Medical News Sentiment PASG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PASG Articles This Week▼171▲PASG Articles Average Week Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRIS News ALVR News PLX News ATHA News OTLK News GRTS News ELUT News DTIL News CGTX News TIL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PASG) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressDoes this make you sick?Allegiance GoldCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
